Effects of buphenine (nylidrin) on the perfused mammalian eye

  • G. Niemeyer
  • D. Cottier
  • H. Resch
Original Investigations


Buphenine (nylidrin), a β-adrenergic agonist, is used therapeutically for its vasodilating effect on the peripheral circulation and possibly on the cerebral circulation as well. In spite of its ophthalmic usage in degenerative retinal disease and glaucoma, buphenine's ocular effects and their mechanisms are not sufficiently established. Consquently, we studied the action of 4.5–120 μM buphenine in isolated, arterially perfused cat eyes, and then used light-evoked electrical signals, perfusion flow rates and the diameters of the retinal vessels as parameters for the drug's effect. Our findings showed that buphenine induced a marked, dose-related, reversible increase in the amplitude of the electroretinogram (ERG) b-wave, a decrease in the c-wave, but no significant changes in the standing potential and light peak of the DC-ERG. The compound action potential of the optic nerve revealed dose-dependent and reversible changes in configuration. However, the flow of perfusate was not affected by the drug, and the diameter of retinal vessels did not change significantly. Our studies suggest that the interaction of buphenine with retinal adrenergic receptors is not related to the vasculature present but to elements involved in information processing. It is likely that these receptors are linked to neurons, since the β-agonist affected the ERG b-waves as well as the compound action potential of the optic nerve.


Glaucoma Optic Nerve Retinal Vessel Cerebral Circulation Retinal Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bruinink A, Dawis S, Niemeyer G, Lichtensteiger W (1986) Catecholaminergic binding sites in cat retina, pigment epithelium, and choroid. Exp Eye Res 43: 147–151PubMedGoogle Scholar
  2. Chader GJ (1984) Cyclic nucleotides of the retina and pigment epithelium. In: Morgan WW (ed) Retinal transmitters and modulators: models for the brain, vol 1. CRC Press, Boca Raton, Florida, pp 1–62Google Scholar
  3. Cottier D, Niemeyer G (1985) Buphenine changes the electroretinogram but not the flow in perfused cat eyes. Experientia 41: 828Google Scholar
  4. Cottier D, Niemeyer G, Resch H (1986) Einfluss von Buphenin auf die Retina des isolierten Säugetierauges. Klin Monatsbl Augenheilkd 188: 532–536Google Scholar
  5. Dawis S, Hofmann H, Niemeyer G (1985) The electroretinogram, standing potential, and light peak of the perfused cat eye during acid-base changes. Vision Res 25: 1163–1177PubMedGoogle Scholar
  6. Eisenberg S, Camp MF, Horn MR (1960) The effect of nylidrin hydrochloride (Arlidin) on the cerebral circulation. Am J Med Sci 240: 85–92Google Scholar
  7. Freedman L (1955) Arlidin — a new vasodilative sympathomimetic drug. Angiology 6: 52–58PubMedGoogle Scholar
  8. Gouras P, Hoff M (1970) Retinal function in an isolated, perfused mammalian eye. Invest Ophthalmol 9: 388–399PubMedGoogle Scholar
  9. Hadjiconstantinou M, Cohen J, Neff NH (1983) Epinephrine: a potential neurotransmitter in retina. J Neurochem 41: 1440–1444PubMedGoogle Scholar
  10. Jacobson JH, Basar D (1956) The effect of a new drug, Nylidrin, upon the electroretinogram. Arch Ophthalmol 56: 865–868Google Scholar
  11. Laties A (1967) Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. Arch Ophthalmol 77: 405–409PubMedGoogle Scholar
  12. Laties AM, Jakobowitz D (1966) A comparative study of the autonomic innervation of the eye in monkey, cat and rabbit. Anat Res 156: 383–395Google Scholar
  13. Nielsen KC, Owman C (1967) Adrenergic innervation of pial arteries related to the circle of Willis in the cat. Brain Res 6: 773–776PubMedGoogle Scholar
  14. Niemeyer G (1973) ERG dependence of flow rate in the isolated and perfused mammalian eye. Brain Res 57: 203–207PubMedGoogle Scholar
  15. Niemeyer G (1975) The function of the retina in the perfused eye. Doc Ophthalmol 39: 53–116PubMedGoogle Scholar
  16. Niemeyer G (1981) Neurobiology of perfused mammalian eyes. J Neurosci Methods 3: 317–337PubMedGoogle Scholar
  17. Niemeyer G (1983) Light modulation of the standing potential in the perfused mammalian eye: characteristics and responses to acidosis. Doc Ophthalmol Proc Ser 37: 41–49Google Scholar
  18. Niemeyer G, Albani C, Schuurmans R (1981) Transmitter-related studies in the isolated, perfused eye of the cat. Vision Res 21: 1661–1663PubMedGoogle Scholar
  19. Niemeyer G, Nagahara K, Demant E (1982) Effects of changes in arterial PO2 and PCO2 on the electroretinogram in the cat. Invest Ophthalmol Vis Sci 23: 678–683PubMedGoogle Scholar
  20. Niemeyer G, Cottier D, Gerber U (1986) Effects of β-agonists on b- and c-waves suggest adrenergic mechanisms in cat retina. Doc Ophthalmol (ISCEV) (in press)Google Scholar
  21. Onoe S, Yoshimura Y, Mori T, Tazawa Y (1985) The effect of beta blocker on rabbit in vivo ERG c-wave. 23rd Symposium ISCEV, Mie, Japan, May 22–25, p 44Google Scholar
  22. Osborne NN (1981) Noradrenaline, a transmitter candidate in the retina. J Neurochem 36: 17–27PubMedGoogle Scholar
  23. Papst N, Demant E, Niemeyer G (1982) Changes in PO2 induced retinal autoregulation in vitro. Graefe's Arch Clin Exp Ophthalmol 219: 6–10Google Scholar
  24. Riegger C (1981) In vitro Versuche in Inkubationsbad zum Studium der Wirkung der vasoaktiven Substanz Serotonin auf die humane Basilararteria. Diploma thesis, Kantonsspital Basel, Departement Forschung, Abteilung NeurobiologieGoogle Scholar
  25. Schlumpf M, Bruininck A, Lichtensteiger W, Cortes R, Palacios JM, Pazos A (1986) β-Adrenergic binding sites in fetal rat C.N.S. and pineal gland: their relation to other receptor sites. Dev Pharmacol Ther (in press)Google Scholar
  26. Steinberg RH, Linsenmeier RA, Griff ER (1985) Retinal pigment epithelial cell contributions to the electroretinogram and electrooculogram. In: Osborne NN, Chader GJ (eds) Progress in retinal research, vol 4. Pergamon Press, New York, pp 33–66Google Scholar
  27. Weigelin E, Niesel P, von dem Wolks D (1953) Über die Wirkung von Dilatol am intrakraniellen Kreislauf. Ärztl Wochenschr 8: 1171–1172Google Scholar
  28. Winsor T, Hyman C, Knapp FM (1960) The cerebral peripheral and circulatory action of Nylidrin Hydrochloride. Am J Med Sci 239: 594–600PubMedGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1987

Authors and Affiliations

  • G. Niemeyer
    • 1
  • D. Cottier
    • 1
  • H. Resch
    • 1
  1. 1.Neurophysiologie-Labor, Augenklinik, UniversitätsspitalZürichSwitzerland

Personalised recommendations